Cavernous Sinus Syndrome

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Cavernous Sinus Syndrome trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingNot Applicable

NCT06214767

Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations

The goal of this observational study is to evaluate and predict the risk associated with cerebral cavernous malformations (CCMs) using advanced artificial intel…

China1,200 participantsStarted 2020-09-01

RecruitingNot Applicable

NCT04076449

Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy

Cerebral cavernous malformation (CCM)-related epilepsy (CRE) impairs the quality of life in patients with CCM. Patients could not always achieve seizure freedom…

China200 participantsStarted 2019-09-03

All recent trials (29 shown)

CompletedPhase 1/2

NCT02603328

Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Tri…

This phase I/II randomized, placebo-controlled, double-blinded, single-site clinical trial is designed to investigate the effect of a prolonged course of atorva…

United States80 participantsStarted 2018-07-17

Treatment: Atorvastatin, Placebo

Active — Not RecruitingNot Applicable

NCT04467489

Biomarkers of CASH

The project aims to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas, a critical cli…

United States1,040 participantsStarted 2020-05-22

Treatment: observational

Cavernous Sinus Syndrome

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations

Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy

All recent trials (29 shown)

Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Tri…

Biomarkers of CASH

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations

Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy

All recent trials (29 shown)

Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Tri…

Biomarkers of CASH

The Symptomatic Cerebral Cavernous Malformation Trial of REC-994

Daratumumab for Familial Cerebral Cavernous Malformations: A Single-Arm Safety and Efficacy Study

Functional Magnetic Resonance Imaging (fMRI) Vascular Reactivity in Cerebral Cavernous Malformations (CCM)

Modifiers of Disease Severity in Cerebral Cavernous Malformations

Role of 18F-FDG PET/CT in the Evaluation of Cavernous Sinus Syndrome: a Pilot Study

CASH (Cavernous Angiomas With Symptomatic Hemorrhage) Trial Readiness

Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation

Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins

Safety and Feasibility of the Infinity Catheter for Radial Access

Endovascular Management of Direct Carotid-cavernous Fistula

CCM Blood Biomarker Validation Study

CoHOrt of Cerebral CavernOus maLformATion: multicEnter Prospective Observational Study

Exploration of Pupil Dilation in Horner's Patients Taking Flomax

Treat_CCM: Propranolol in Familial Cerebral Cavernous Malformation

Cerebral Blood Flow Evaluation With Trancranial Doppler After Interscalene Nerve Block

The Effects of Horner's Syndrome Developing After Interscalene Brachial Plexus Block on Autonomic Nervous Activity

Pupillometry in Horner's Syndrome

Treatments and Outcomes of Untreated Cerebral Cavernous Malformations in CHina.